Nautilus Biotechnology Inc (NAUT) — Financial Flexibility Index
Nautilus Biotechnology Inc (NAUT) has a Financial Flexibility Index of -0.33x as of September 2025. Free cash flow of $-10.62 Million (operating CF $-11.03 Million minus capex $418.00K) represents 0% of total liabilities ($31.78 Million). Check Nautilus Biotechnology Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nautilus Biotechnology Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Nautilus Biotechnology Inc across 7 annual periods. For the full cash flow conversion analysis, see Nautilus Biotechnology Inc (NAUT) cash conversion ratio.
Annual Financial Flexibility Index for Nautilus Biotechnology Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Nautilus Biotechnology Inc. Explore NAUT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.68x | $-57.02 Million | $-59.15 Million | $34.01 Million | ▼ -36.8% |
| 2023 | -1.23x | $-49.27 Million | $-51.71 Million | $40.21 Million | ▲ +1.0% |
| 2022 | -1.24x | $-43.48 Million | $-45.81 Million | $35.13 Million | ▼ -16.8% |
| 2021 | -1.06x | $-36.97 Million | $-39.24 Million | $34.87 Million | ▼ -830.3% |
| 2020 | -0.11x | $-13.07 Million | $-14.00 Million | $114.73 Million | ▲ +99.4% |
| 2019 | -17.83x | $-8.74 Million | $-9.66 Million | $490.00K | ▼ -953.6% |
| 2018 | -1.69x | $-238.30 Million | $-238.30 Million | $140.82 Million | — |